DatasetName,HIVEP1_C(2303) HIVEP1_S(1036) HIVEP1_S(1051) HIVEP1_S(1141) HIVEP1_S(1147) HIVEP1_S(1156) HIVEP1_S(1158) HIVEP1_S(1180) HIVEP1_S(1213) HIVEP1_S(124) HIVEP1_S(130) HIVEP1_S(148) HIVEP1_S(1735) HIVEP1_S(1749) HIVEP1_S(1753) HIVEP1_S(1873) HIVEP1_S(1874) HIVEP1_S(1884) HIVEP1_S(1952) HIVEP1_S(2032) HIVEP1_S(2033) HIVEP1_S(2221) HIVEP1_S(2299) HIVEP1_S(2327) HIVEP1_S(2341) HIVEP1_S(2596) HIVEP1_S(2598) HIVEP1_S(2599) HIVEP1_S(2676) HIVEP1_S(2681) HIVEP1_S(2682) HIVEP1_S(41) HIVEP1_S(476) HIVEP1_S(479) HIVEP1_S(487) HIVEP1_S(492) HIVEP1_S(495) HIVEP1_S(523) HIVEP1_S(537) HIVEP1_S(571) HIVEP1_S(577) HIVEP1_S(589) HIVEP1_S(637) HIVEP1_S(65) HIVEP1_S(664) HIVEP1_S(687) HIVEP1_S(694) HIVEP1_S(698) HIVEP1_S(749) HIVEP1_S(776) HIVEP1_S(779) HIVEP1_S(804) HIVEP1_S(812) HIVEP1_S(862) HIVEP1_S(866) HIVEP1_T(1025) HIVEP1_T(2034) HIVEP1_T(569) HIVEP1_T(699) HIVEP1_T(815),HIVEP1_S(1733) HIVEP1_S(681)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5017819910681728,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.5053053638917484,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5036336220271223,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5010438017778511,
RKK2015_TNF-α/basal,0.5183806129670749,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.49947316584735674,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,0.5027771819195895,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.49697212791370265,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5049720868911746,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5038758360893871,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.49795451949770153,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5103301961373786,
FSO2013_Ratio M/L normalized Rep1___1,0.5043608514016761,
SAS2015_AZD/DMSO_Exp3,0.5066636946383116,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.512284593179824,
WZ2023_Pu_010_30min,0.5004502253991661,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5012261273077521,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.5018634355011156,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5001106080108803,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.501563610490328,
AH2018_SILAC_MR_2_N,0.5000101550555285,
MV2014_Ratio M/L normalized A1___2 (2 min),0.5131302701939894,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5084254953601216,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.49034164319252543,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5037220549400011,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.4995734441559768,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5005837588657559,
WZ2023_Pu_005_10min,0.5036983474541598,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5084289463274092,
AH2018_SILAC_MR_2_X,0.5008711253414292,
HS2024_4_PD_T2,0.5026297130499423,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5062494503905769,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.49915889236736,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.500525398793026,
HS2024_7_PD_T2,0.4965435015768335,
FSO2013_Ratio H/L normalized Rep1___1,0.5038860855157368,
AH2018_LFQ_1_C,0.5015036388562794,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5019008354007352,
HS2024_3_B_N1,0.498955619681249,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5000190887711583,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.49825140463848744,
MV2014_Ratio H/M normalized A2___2 (2 min),0.5103331511861727,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.4998309626882721,
FSO2013_Ratio H/L normalized Rep2,0.5046112390147732,
WZ2023_Pu_005_20min,0.5029503770109159,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5077907965664239,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.503921930537188,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.500031454193193,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5017724338256665,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5054343479826436,
FSO2013_Ratio M/L normalized Rep3___2,0.5035545697202365,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5063644253454143,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5202707529363225,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.5021578728048985,
PG2020_Intensity Mock_10h_D,0.49650864133255296,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5048443567861134,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5018410540169097,
RCJD2014_5min_1,0.5055574398173277,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.50507255257686,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.5029965919820608,
CR2017_Ratio Replicate 3.3,0.5033671040608061,
PG2020_Intensity 2h_C,0.4943633922030453,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.502347422403987,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.501345521460869,
RN2012_L11,0.5069123842877429,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.49680991236818084,
HS2024_5_PD_T1,0.5066460547776901,
AH2018_LFQ_M_2_C,0.49995876001137446,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5064165087858538,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.49864464990354196,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.49931612668735054,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5028288001494864,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5003697173298061,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.5135448190750925,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),0.5004869384758125,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.49837600247703046,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5038566620136862,
HS2024_8_I_T3,0.5031712200175056,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.4991635385551268,
DL2023_12h-2,0.5007114350308971,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5038893740330156,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.5067486981831806,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5017675211866315,
FSO2013_Ratio H/M normalized Rep2,0.5038134063563876,
RAM2015_Log2 A,0.4975298622330443,
HS2024_8_PD_T1,0.509315713499162,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.49926367621886836,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5024313737361793,
HS2024_7_I_T1,0.5048646004286855,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.5038260031474296,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5104246481729663,
AH2018_SILAC_M_3_X,0.4995712931318745,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.5052870572522894,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5022534547615547,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.4994144874973493,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5127342882320685,
HS2024_6_B_N1,0.49452160219803704,
KBE2022_Log2_Ex_27_T,0.5012536264089934,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.4994954149952121,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,0.5001093860644554,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5028961825839314,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5013095795599902,
DL2023_control-1,0.49904737212502404,
AR2021_ALG 10 μM,0.5131673881882883,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.49804607064376394,
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5054321541088374,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5009987193375781,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.505130961869376,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5010522785626976,
JW2021_After_3,,
GF2025_P8_Sph,0.5054754124569831,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5000240798550185,
CK2022_11 200-1,0.5002186501722119,
CK2022_12 200-1,0.5004835368015867,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5023428709488652,
WZ2023_Su_010_20min,0.4974509536938861,
AH2018_TMTMS2_2_N,0.5012867666123967,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.49917468346121574,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.49560208538396033,
KS2014_Intensity N4,0.4972424388410671,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.5024643581973826,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.4991665969447591,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.4927052541072246,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.5018869354684227,
GF2025_P1_Sph,0.5027620751255518,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.5013807178625924,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5023803355645903,
CF2017_EOC 1,0.4985481935054363,
CK2022_3 200-1,0.5020620490262419,
AH2018_LFQ_IT_3_C,0.5005882953984043,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5076168011611314,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.49990414763958324,
HS2024_5_B_T1,0.5062912856539383,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.5010007036440106,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5120705568062736,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.501925419423091,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.4996426958885168,
HS2024_4_B_T1,0.5108217502762288,
MV2014_Ratio M/H normalized A3___1 (10 min),0.5014083314152412,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5019488034693613,
CR2017_Ratio Replicate 3.2,0.5049778983433583,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5029882989729503,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5022962141164085,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5018344815209984,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5024372939617073,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.4980399144010123,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.49824647931930677,
HS2024_5_PD_T3,0.5148783619690445,
AH2018_TMTMS3_3_X,0.5000712918682532,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5025760856897995,
AH2018_LFQ_M_1_N,0.5038181791489043,
KBE2022_Log2_Ex_27_U,0.5024234599158506,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.5036996861497559,
AH2018_SILAC_M_1_N,0.5021884896119303,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.4964433278159255,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,0.5015910872447512,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5021140965427018,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5025601306895735,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.508278678958571,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5042537341331423,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5035458403181025,
HH2022_Reporter intensity 6,0.49904505261612364,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5064596148973377,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5010359342494388,
GF2025_P3_Adh,0.5011505574260866,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5032444466410421,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5013166551645782,
KBE2022_Log2_Ex_19_U,0.5027822809405008,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5061677353810664,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5015015719635626,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.5046192881607944,
AH2018_LFQ_1_X,0.4988799287968701,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5065913363132112,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5021084462098478,
HH2022_Reporter intensity 1,0.5054685211724294,
HH2022_Reporter intensity 2,0.5053614225795339,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5051710133036296,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5013010862771143,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.503722444488467,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5062866583087808,
AR2021_KD 72h,0.5002757031561489,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5026177221389007,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.49976005423828723,
KBE2022_Log2_Ex_9_U,0.5030782036533634,
AH2018_SILAC_M_3_N,0.5006965056354429,
KBE2022_Log2_Ex_13_T,0.5026267093903944,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.495393817116396,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.5230779367355867,
PG2020_Intensity 10h_A,,
RN2012_L12,0.5053374481384277,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5007123355292095,
SAS2015_PLX/AZD_Exp1,0.5162547064387915,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5017616374234378,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5098208268843543,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.4955850597140008,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.4978336240144244,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5033876737594388,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.49757472131274,
CK2022_7 200-1,0.5012394108141189,
CK2022_5 200-1,0.5012055574940079,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5046817397560363,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5026075548963214,
AH2018_SILAC_MR_1_X,0.49996830317951757,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.49750082053422484,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.4982294660745911,
AH2018_SILAC_3_C,0.5007167770999181,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5013744563030642,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5019756530424399,
SAS2015_PLX/DMSO_Exp1,0.5130458703613001,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5023769046847518,
FSO2013_Ratio H/L normalized Rep3,0.5046656268160188,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.5088695027045773,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.49849949108424185,
KBE2022_Log2_Ex_9_T,0.5028480323926535,
AH2018_SILAC_IT_2_N,0.49604467831708454,
AH2018_SILAC_IT_1_X,0.4998615143396045,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.4916907371236416,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.503001152682129,
WZ2023_Pe_025_20min,0.5009012542950972,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.4991082758209839,
HS2024_4_I_N2,0.5072349092459194,
AH2018_TMTMS2_3_N,0.5031670454569656,
RN2012_H06,0.509340783567033,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5230221601994808,
WZ2023_Su_005_30min,0.5033119551947711,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.4992547864354302,
WZ2023_Su_025_10min,0.49859143163440023,
AH2018_LFQ_IT_4_X,0.4991558648457581,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5027070106619175,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.48045325447470977,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5091206553936487,
MV2014_Ratio H/M normalized A2___1 (2 min),0.5044649605963026,
PG2020_Intensity 8h_D,0.5009124428181619,
LY2019_P7+,0.5068100715755671,
EP2017_Untreated R#1 normalized log2 ratio,0.5164151293115935,
RN2012_L10,0.5020878428262716,
PG2020_Intensity 4h_C,0.5028477354285861,
EP2017_Mitotic R#3 normalized log2 ratio,0.5010347721188009,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.49727396782103206,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.49781447683330526,
HS2024_4_B_T3,0.5027319061410803,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5124446471148031,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.5079430010990712,
KBE2022_Log2_Ex_6_U,0.502949500181743,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5050010680518553,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5027794298611484,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5005731753919526,
GF2025_P9_Sph,0.5036445445193206,
CK2022_6 200-1,0.5012314261930403,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.49895328378025516,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.5105092740783609,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.517402254376534,
SAS2015_AZD/DMSO_Exp1,0.512880472757689,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.499924831227316,
HS2024_3_B_T3,0.5096878932895206,
MV2014_Ratio L/H normalized A3___2 (2 min),0.5079312923618946,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.49569640161300826,
EP2017_Untreated R#3 normalized log2 ratio,0.49212490712322804,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5014266192964417,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.504880722925954,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.49607382205151723,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5005853351682987,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5099700505261909,
KBE2022_Log2_Ex_29_T,0.5025514260325546,
HS2024_7_I_T2,0.5006667265947154,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5054073864580653,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.5108706753092924,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5004491230398194,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.4916888977775798,
ZCP2016_Ratio H/L Rep 1,0.49750389234880465,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5037126571744501,
EP2017_Untreated R#3 log2 ratio,0.4926391085244445,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5041275369576814,
HS2024_8_PD_T2,0.5088242014792163,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5036634632144908,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5036066985279252,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.505220075559513,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5009866373852886,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.520978615353649,
HS2024_3_PD_T3,0.5097076865389983,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.4892961991831816,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5011432348488267,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5021965980663364,
CK2022_2 16-1,,
RAM2015_Log2 B,0.4996565293486824,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.5036415511821266,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5093316611870244,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5120150420346947,
PG2020_Intensity Mock_10h_B,0.4958932317733994,
WZ2023_Su_025_30min,0.5013227675140557,
AH2018_LFQ_4_N,0.5014482138325717,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5132529372281511,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5006041059410351,
AH2018_SILAC_M_1_X,0.5014479438896442,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.49977530846282125,
LY2019_P6+,0.4988982150739556,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5044056293071485,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5138769382832158,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),0.503430004324361,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.49782418643467774,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5050560320261436,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5044717365997743,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5047134893143883,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5041436528837259,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5019594398975056,
AH2018_LFQ_2_X,0.49923678000053445,
PG2020_Intensity 2h_B,0.4917498781963403,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.4990626153425702,
GF2025_P3_Sph,0.5042416508093426,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5010512389905282,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5016258439212492,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.49807117717594146,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5023191771732378,
ZQ2022_N1,,
LY2019_P6-,0.5017746707363044,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),0.5042622967624159,
RN2012_L14,0.504804220370912,
AH2018_LFQ_3_N,0.5015838707314803,
RKK2015_TNF-α/IKKb,0.5075980194741821,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.503858490753015,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.49797520732661005,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5153977598413658,
WZ2023_Su_025_20min,0.4953288868033879,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.4972512014866582,
LY2019_P8-,0.5050074035770068,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.503206442667135,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5034619059788601,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5127371389323162,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.4781379089642566,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5043548629774903,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5011413004750301,
AH2018_LFQ_M_4_C,0.5005328947393027,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.50036195820695,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5088998973623944,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.503265906100879,
LY2019_P3-,0.49907215061658383,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),0.5023000549190276,
WZ2023_Pe_005_30min,0.5013764385164975,
HS2024_8_PD_T3,0.5021929982651545,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.4956146642936959,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5016071194289159,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5037360438109667,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5107583379366271,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5015038531139343,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.49980365468376436,
HS2024_8_I_N2,0.5050556996906133,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5022567354585754,
LY2019_P8+,0.5041780169117547,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5004741846461682,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5017224263655373,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.5083511313127224,
AH2018_LFQ_IT_1_X,0.5010055694940422,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.4992488495780559,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5015120668322975,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5037210147501308,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.5104239663318314,
HS2024_6_I_T1,0.4995928243473813,
HS2024_5_B_T3,0.5162462330818757,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5037768962491685,
AH2018_TMTMS3_3_N,0.49929528335064793,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5012730024347721,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.49620477998367263,
KBE2022_Log2_Ex_36_T,0.5036230170057101,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5038343410036741,
KS2014_Intensity C2,0.5059588007856043,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5023927070288858,
CK2022_9 200-1,0.5000610289089932,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5000017989074581,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5072667306488648,
RBK2021_1332T Late,,
LY2019_P1-,0.5038655694557468,
RKK2015_TNF-α/basal.1,0.5116802861174758,
RKK2015_TNF-α/TNF-α+SC-514,0.5137476665303214,
CR2017_Ratio Replicate 2.5,0.5033693495310596,
HS2024_3_I_T3,0.5025773807595988,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.50216584953155,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5029802520049498,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.516839529378758,
RKK2015_SC-514/basal,0.5191962287772741,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.49671542601959134,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5048461925224319,
KS2014_Intensity N1,0.5044143884979146,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5051222437106649,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5019846942036102,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.4993913527710058,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5013346445703337,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.506220280129505,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.508053318887717,
HS2024_5_B_N2,0.5129489035340161,
HS2024_5_I_N1,0.5168440198654899,
HS2024_6_I_N1,0.4984165249766631,
AR2021_KD 48h,0.4944680451716799,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.514066226760624,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5002792417655108,
KBE2022_Log2_Ex_29_U,0.5034212852060953,
HS2024_7_B_T1,0.5000328772227322,
AH2018_LFQ_M_2_X,0.4988091443348718,
AH2018_LFQ_IT_4_N,0.5003711426833722,
CK2022_15 200-1,0.5019927288722397,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.4994204241650549,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5145746458975707,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5019571322887266,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),0.507958216671051,
WZ2023_Su_010_30min,0.4971493122234084,
RN2012_H01,0.502704970021974,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.4914347797832155,
HS2024_8_B_T3,0.501323748537537,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5000125999962806,
WZ2023_Pe_010_20min,0.5021713982108148,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5023922393732417,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5060869894502952,
KS2014_Intensity C1,0.506694345724564,
FSO2013_Ratio H/M normalized Rep3___1,0.5062701259527135,
AH2018_SILAC_M_3_C,0.5010804465118058,
RKK2015_TNF-α+IKKb/TNF-α,0.5096612177932051,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5009862828636453,
AH2018_SILAC_M_2_X,0.49818571744492585,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5027220251876038,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.49746633623169456,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5013124933888077,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5043817713722749,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.5027489797914664,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5065498931498729,
GF2025_P8_Adh,0.5040913956257662,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5050582839853036,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5094334677479238,
IMM2018_normalised rep. int. CDK5L-1,0.500194113940743,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.49328488480634874,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.504944125604063,
CF2017_EOC 2,0.5017729137972302,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5017726144706689,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5131393561452531,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5057577606823943,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5019504241528636,
AR2021_L41 1 μM,0.5065958892621729,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5025693385048552,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.5098321986926331,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5009896597032609,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5024184115487802,
MV2014_Ratio H/M normalized B2___1 (5 min),0.5030023576549737,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5011600179895926,
SAS2015_PLX/DMSO_Exp3,0.5016173370097768,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5040365040347445,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5007287234426997,
WZ2023_Pu_025_10min,0.5035708530122134,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.501910696133271,
FSO2013_Ratio M/L normalized Rep3___1,0.501289522655317,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.4976340244733182,
CF2017_EOC 4,0.5010065398897178,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5037595853450868,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5000116626031345,
KS2014_Intensity C6,0.49890946577759876,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.4998531368245976,
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5002307066531645,
UK2020_UA_3,,
LY2019_P7-,0.5065379020611743,
GF2025_P5_Adh,0.5015610203246118,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.50475551781816,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5056048552624266,
PG2020_Intensity CT_B,0.4903232605898766,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.4998841222813131,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5030818583666435,
AH2018_LFQ_3_C,0.5019044703801859,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.49859685821579697,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.505668841887389,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.4973615698428678,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),0.506904738123188,
KBE2022_Log2_Ex_19_T,0.5016559242304668,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.5001869392763844,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.49539698860307374,
AH2018_TMTMS2_1_X,0.5009569367809426,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.490546403181403,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.492255345298569,
HH2022_Reporter intensity 4,0.5028494918140144,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5060562563905125,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.5030083531295759,
AH2018_SILAC_1_X,0.5010227834464416,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.4981145771255886,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5127959050144298,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.501581701250481,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.5019187440463256,
EP2017_Untreated R#2 normalized log2 ratio,0.500900690263055,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5058351794150704,
HS2024_5_I_N2,0.512382857942795,
SAS2015_PLX/AZD_Exp3,0.5076884908907172,
EP2017_Pervanadate R#2 log2 ratio,0.4819920125525492,
AS2011_Ratio H/L Normalized RNAi_2_1,,
